Hanlim Pharm Co., Ltd.
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Private
- Established
- 1989-03-14
- Employees
- 251
- Market Cap
- -
- Website
- http://hanlim.com
Clinical Trials
49
Active:2
Completed:33
Trial Phases
4 Phases
Phase 1:20
Phase 2:6
Phase 3:12
+1 more phases
Drug Approvals
12
PHILIPPINES:12
Drug Approvals
- Prev
- 1
- 2
- Next
Clinical Trials
Distribution across different clinical trial phases (42 trials with phase data)• Click on a phase to view related trials
Phase 1
20 (47.6%)Phase 3
12 (28.6%)Phase 2
6 (14.3%)Phase 4
4 (9.5%)Study to Evaluate the Bioequivalence of Vonopzan Tablet 20mg(Vonoprazan Fumarate) and Vocinti Tablet 20mg in Healthy Adult Subjects.
Phase 1
Completed
- Conditions
- Gastric Ulcer
- Interventions
- First Posted Date
- 2024-10-15
- Last Posted Date
- 2024-10-16
- Lead Sponsor
- Hanlim Pharm. Co., Ltd.
- Target Recruit Count
- 30
- Registration Number
- NCT06642987
- Locations
- 🇰🇷
Seok Gyeong Medical Foundation Central Hospital, Siheung-si, Korea, Republic of
Study to Evaluate the Bioequivalence of "Crecheck Tablet 2.5 mg (Rosuvastatin Calcium)" and "Crestor Tablet 5 mg (Rosuvastatin Calcium)" in Healthy Adult Subjects
Phase 1
Completed
- Conditions
- Primary HypercholesterolemiaCombined Hyperlipidemia
- Interventions
- Drug: Crecheck Tablet 2.5 mg
- First Posted Date
- 2024-06-26
- Last Posted Date
- 2024-06-27
- Lead Sponsor
- Hanlim Pharm. Co., Ltd.
- Target Recruit Count
- 36
- Registration Number
- NCT06475872
- Locations
- 🇰🇷
Seok Gyeong Medical Foundation Central Hospital, Gyeonggi-do, Korea, Republic of
Study to Evaluate Efficacy and Safety of Bronpass Tab. in Patients With Chronic Obstructive Pulmonary Disease
Phase 2
Recruiting
- Conditions
- Chronic Obstructive Pulmonary Disease
- Interventions
- Other: PlaceboDrug: Bronpass Tab.
- First Posted Date
- 2024-05-30
- Last Posted Date
- 2024-05-30
- Lead Sponsor
- Hanlim Pharm. Co., Ltd.
- Target Recruit Count
- 96
- Registration Number
- NCT06434792
- Locations
- 🇰🇷
Konkuk University School of Medicine, Seoul, Korea, Republic of
Evaluation of the Clinical Efficacy and Safety of BriTurn Injection or BrisTurn Prefilled Injection
Recruiting
- Conditions
- Reversal of Neuromuscular Blockade
- First Posted Date
- 2024-02-07
- Last Posted Date
- 2024-02-07
- Lead Sponsor
- Hanlim Pharm. Co., Ltd.
- Target Recruit Count
- 1500
- Registration Number
- NCT06246331
- Locations
- 🇰🇷
Inje University Sanggye Paik Hospital, Seoul, Korea, Republic of
An Observation Study on the Identification of Prescription Patterns of Lodient Tab(Telmisartan/S-amlodipine)
Recruiting
- Conditions
- Hypertension
- First Posted Date
- 2024-01-22
- Last Posted Date
- 2024-01-22
- Lead Sponsor
- Hanlim Pharm. Co., Ltd.
- Target Recruit Count
- 4000
- Registration Number
- NCT06214832
- Locations
- 🇰🇷
Seoul song clinic, Seoul, Korea, Republic of
- Prev
- 1
- 2
- 3
- 4
- 5
- 10
- Next
News
No news found